The primary outcome measures were perioperative change in hemoglobin and the proportion of patients requiring an allogenic
Blood-conserving strategies to minimise allogenic
transfusion include optimising preoperative haemoglobin, use of autologous donation, minimising intraoperative blood loss (including surgical technique, cell salvage and antifibrinolytics) and implementing restrictive transfusion strategies (7).
Zone II flexor tendon defects may be bridged by the use of an allogenic
acellularized intrasynovial tendon scaffold repopulated with intrasynovial epitenon and endotenon cells.
Patient Age Diagnosis Treatment Date 1 5 Malignant Autologous 01/02/2008 lymphoma PSC infusion 2 5 Primary Allogenic
CB 12/02/2008 thrombocytopenia infusion 3 4 Neuroblastoma Autologous 05/03/2008 HPC, marrow infusion Table 2.
The patient experienced a relapse of multiple myeloma in August 1999, and he received an allogenic
stem cell transplant on October 11, 1999.
She was given chemotherapy, and in July 1990, when her cancer was in remission, the patient received an allogenic
bone marrow transplant from her sister at Ohio State University (OSU) Hospitals.
This means that about five percent of patients with AML have this defect and need to be treated quickly and aggressively," Caligiuri indicates, adding that those with the defect probably should undergo an allogenic
bone marrow transplant while in their first remission of the disease if that option is a possibility.
AUTOLOGOUS BLOOD TRANSFUSIONS VIS-A-VIS ALLOGENIC
The source of donor tissue can be xenogenic (divergent species), allogenic
(same species, divergent individual), or autogenic (same individual).
If the company is engaged in research of multiple cell types, but is mostly focusing on autologous cells, but also has projects using allogenic
cells and is just starting the induced stem cell program, each one of these fields will be color coded by the level of activity in the field.
From the viewpoint of clinical translation allogenic
stem cells are attractive because they can be easily obtained from young healthy donors, amplified, and stored for immediate use when needed after a stroke, the researchers wrote.
Treatments described include autologous hematopoietic stem cell transplantation, allogenic
stem cell transplantation, and non-transplant-based salvage therapy.